Title:
ANTI-CD52 ANTIBODY TREATMENT FOR DIABETES
Document Type and Number:
WIPO Patent Application WO2005062893
Kind Code:
A3
Abstract:
The present invention provides for the prevention and/or treatment of Type 1 diabetes mellitus with CD52 specific antibodies, e.g. CAMPATH-1H.
Inventors:
ARTHAUD LARRY E (US)
Application Number:
PCT/US2004/043142
Publication Date:
December 29, 2005
Filing Date:
December 22, 2004
Export Citation:
Assignee:
ILEX PRODUCTS INC (US)
ARTHAUD LARRY E (US)
ARTHAUD LARRY E (US)
International Classes:
A61K39/395; C07K16/28; (IPC1-7): A61K39/395
Other References:
WINTER ET AL: "Prevention Strategies for Type 1 Diabetes Mellitus Current Status and Future Directions.", BIODRUGS., vol. 17, no. 1, 2003, pages 39 - 64, XP008059735
Download PDF:
Previous Patent: DEVICE AND METHODOLOGY FOR IMPROVED MIXING OF LIQUIDS AND SOLIDS
Next Patent: CO-ADMINISTRATION OF DOPAMINE-RECEPTOR BINDING COMPOUNDS
Next Patent: CO-ADMINISTRATION OF DOPAMINE-RECEPTOR BINDING COMPOUNDS